The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Industry Views

The increasing practice of smartphones and tablets universally has assisted in an increase in the mobile television market. Maximum smartphones and tablets nowadays are TV empowered and this has given...

The launch of medical wearable devices has enhanced the growth of the global medical devices market. Major players in the global medical devices market are busy in mechanizing trailblazing yet economi...

The global end-of-line packaging market is set for massive upheaval in the coming years. The intensity of competition in the market is predicted to upsurge as the manufacturers are concentrating on in...

Medical robotics is up-and-coming area of healthcare. An extensive range of medical applications has materialized like laboratory robots, surgical robots, telesurgery, remote surgery, and teleconsulta...

Robots and drones have, at present, started to gently alter many facets of agriculture. This is by now a US$ 3 billion market in 2016 and is expected to grow to US$10 billion by 2022. Robotics has see...

Company Profile: 23andMe
Summary
23andMe is a personal genomics and biotechnology company that leverages machine learning technology to provide DNA analysis services. It also offers web-based interactive tools to individuals, helping them understand their own genetics information.
Scope
The report provides information and insights into 23andMe, including -
- Overview of the company and its product offering
- Detailed insight into its business operation, technology, revenue model, geographical presence and business model
- Information on partnerships, funding and awards it received
- Biography of top management.
Reasons to buy
- Gain insights into 23andMe's business operations.
- Gain insights into funding and partnerships.
- Gain understanding about its technology focus and success ......

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India
Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - India". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in India. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of India. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by ......

The State of the Microbiome
Summary
GlobalData's "The State of the Microbiome", report provides an assessment of how the pharmaceutical industry perceives the state of the microbiome, including the challenges associated with developing, launching, and manufacturing microbiome therapeutics as well as where opportunity remains to invest in the microbiome space.
Scope
- Microbiome investment - determine level of activity and investment in the development of microbiome therapeutics by therapy area
- Identify the challenges associated with
- Developing microbiome therapeutics
- Launching microbiome therapeutics
- Manufacturing microbiome therapeutics.
Reasons to buy
- Develop and design your corporate strategies in the microbiome space by understanding the challenges associated with devel......

Rheumatoid Arthritis: Epidemiology Forecast to 2027
Summary
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body's immune system attacks the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory response. The disease can lead to premature mortality, disability, and decreased quality of life.
GlobalData epidemiologists used sources that provided the diagnosed incidence, diagnosed prevalence, and total prevalence of RA based on the 1987 American College of Rheumatology (ACR) criteria and International Classification of Diseases, Tenth Edition (ICD-10): M05 and M06.
In 2......

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2018
Summary
GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q3 2018", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q3 2018. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides informati......

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China
Summary
GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - China". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in China. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of China. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by ......